Notable Analyst Rating Changes 6/9: X, CSX, OMTR, MRVL Higher; HIG, VRX, MAS Lower
Up)
UPGRADES:
Morgan Stanley upgrades U.S. Steel (NYSE: X) from Equal-weight to Overweight.
Goldman Sachs upgrades CSX Corp. (NYSE: CSX) from Neutral to Buy and raises their price target from $36 to $40.
Morgan Stanley upgrades Omniture (Nasdaq: OMTR) from Equalweight to Overweight. Click here to see full color on the upgrade.
JMP Securities upgrades Marvell Technology (Nasdaq: MRVL) from Underperform to Outperform.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citigroup downgrades Hartford Financial (NYSE: HIG) from Buy to Hold and lowers their price target from $21 to $19, citing a management vacuum after Chairman/CEO Ayer announced plans to retire.
Wachovia downgrades Valeant Pharmaceuticals (NYSE: VRX) to Underperform. Valuation Range: $15 to $17. Click here for the full report.
UBS downgrades Masco (NYSE: MAS) from Neutral to Sell.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Sanford C. Bernstein initiates coverage on State Street (NYSE: STT) with an Outperform rating.
Brean Murray Initiates Coverage on athenahealth (Nasdaq: ATHN) with a Buy. Click here for more color on the coverage.
J.P. Morgan initiates coverage on CarMax (NYSE: KMX) with a Neutral rating. Price target $15.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Morgan Stanley upgrades U.S. Steel (NYSE: X) from Equal-weight to Overweight.
Goldman Sachs upgrades CSX Corp. (NYSE: CSX) from Neutral to Buy and raises their price target from $36 to $40.
Morgan Stanley upgrades Omniture (Nasdaq: OMTR) from Equalweight to Overweight. Click here to see full color on the upgrade.
JMP Securities upgrades Marvell Technology (Nasdaq: MRVL) from Underperform to Outperform.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citigroup downgrades Hartford Financial (NYSE: HIG) from Buy to Hold and lowers their price target from $21 to $19, citing a management vacuum after Chairman/CEO Ayer announced plans to retire.
Wachovia downgrades Valeant Pharmaceuticals (NYSE: VRX) to Underperform. Valuation Range: $15 to $17. Click here for the full report.
UBS downgrades Masco (NYSE: MAS) from Neutral to Sell.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Sanford C. Bernstein initiates coverage on State Street (NYSE: STT) with an Outperform rating.
Brean Murray Initiates Coverage on athenahealth (Nasdaq: ATHN) with a Buy. Click here for more color on the coverage.
J.P. Morgan initiates coverage on CarMax (NYSE: KMX) with a Neutral rating. Price target $15.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
You May Also Be Interested In
- Notable 52-Week Highs and Lows of the Day 05/25: (LCC) (RPRX) High; (DCTH) (MXWL) (VIP) Low
- Unusual 11 Mid-Day Movers 05/24: (GENE) (GNOM) (SWSH) Higher; (NTAP) (SIG) (LDK) Lower
- Notable ETF Movers of the Day 05/24: (EPI) (SLV) (VXX) Higher; (UNG) (FXI) Lower
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Brean Murray Carret & Co., UBS, JPMorgan, Goldman Sachs, Citi, Morgan Stanley, Wachovia, Sanford C. Bernstein, JMP Securities, Notable Analyst Rating ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
